IP Library Assignment 043022/0696
Patent Assignment
Reel/Frame 043022/0696

Release of Security Interest

Recorded: 2017-07-17 Pages: 9
Assignor
MEDICURE INC.
Executed: 2017-07-10
Assignee
APICORE US LLC
49 NAPOLEON COURT, SOMERSET, NEW JERSEY, 08873
Covered Properties (21)
Process for Preparation of 5H-Dibenzo[a,D] Cycloheptene Derivatives
Patent: 7,446,227 →
Application: 11/609,075 →
Publication: US 2008/0139848
Process for Preparation Isosulfan Blue
Patent: 7,662,992 →
Application: 12/180,057 →
Publication: US 2008/0293963
Process for the Preparation of Cis-2-Methylspiro (1, 3-Oxathiolane 5-3') Quinuclidine
Patent: 8,450,487 →
Application: 12/796,308 →
Publication: US 2011/0301352
Process for Preparation of Isosulfan Blue
Patent: 9,353,050 →
Application: 13/310,019 →
Publication: US 2012/0078007
Process for Preparing Saxagliptin and Its Novel Intermediates Useful in the Synthesis Thereof
Patent: 8,748,631 →
Application: 13/479,975 →
Publication: US 2013/0023671
Process for Preparation of Isosulfan Blue
Patent: 8,969,616 →
Application: 13/951,034 →
Publication: US 2013/0310600
Process for Preparing Saxagliptin and Its Novel Intermediates Useful in the Synthesis Thereof
Patent: 9,150,511 →
Application: 14/264,770 →
Publication: US 2014/0235870
Process for Preparing Heparinoids and Intermediates Useful in the Synthesis Thereof
Application: 14/338,927 →
Publication: US 2014/0336369
Methods of Making Netupitant and Intermediates Thereof
Application: 14/703,178 →
Publication: US 2015/0315149
Methods of Making Carfilzomib and Intermediates Thereof
Application: 14/923,068 →
Publication: US 2016/0115198
Processes for Making Ponatinib and Intermediates Thereof
Patent: 9,493,473 →
Application: 14/984,446 →
Publication: US 2016/0108053
Process of Making Regadenoson and Novel Polymorph Thereof
Application: 15/013,887 →
Publication: US 2016/0244474
Process for Preparation of Isosulfan Blue
Application: 15/095,791 →
Publication: US 2016/0221936
Processes for Making Ponatinib and Intermediates Thereof
Patent: 9,988,389 →
Application: 15/178,813 →
Publication: US 2016/0362411
Methods of Making Carfilzomib and Intermediates Thereof
Patent: 9,822,145 →
Application: 15/228,689 →
Publication: US 2016/0340388
Processes for Making Ponatinib and Intermediates Thereof
Application: 62/174,083 →
Processes for Making Ponatinib and Intermediates Thereof
Application: 62/175,721 →
Processes for Making Ponatinib and Intermediates Thereof
Application: 62/204,571 →
Process for the Preparation of Novel Polymorphic Forms of 5-Fluoro-1,3-Dihydro-1-Hydroxy-2,1-Benzoxaborole
Application: 62/358,775 →
Methods of Making Eribulin Mesylate
Application: 62/358,921 →
Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
Application: 62/440,708 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 27, 2007
From: NAMPALLI, SATYAM; PATEL, BRIJESH; THARIAL, PETER XAVIER; KOVI, RAVISHANKER
To: APICORE, LLC
Reel/Frame 019486/0533 →
Assignment of Assignor's Interest Sep 1, 2010
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; CHOWDARI, TALLURI BUHSHAIAH; SHAH, CHIRAG VASANTLAL
To: APICORE, LLC
Reel/Frame 024922/0407 →
Assignment of Assignor's Interest Oct 5, 2012
From: KOVI, RAVISHANKER; RAPOLE, KESHAVRAO; NAIK, ASHISH; KANNAPAN, JAYARAMAN
To: APICORE, LLC
Reel/Frame 029084/0721 →
Security Interest Jul 3, 2014
From: APICORE LLC
To: KNIGHT THERAPEUTICS INC., AS AGENT
Reel/Frame 033277/0320 →
Assignment of Assignor's Interest Jul 7, 2014
From: APICORE LLC
To: APICORE US LLC
Reel/Frame 033254/0007 →
Security Interest Jul 8, 2014
From: APICORE US LLC
To: KNIGHT THERAPEUTICS INC., AS AGENT
Reel/Frame 033281/0920 →
Merger and Change of Name Jul 15, 2014
From: APICORE LLC; APICORE US LLC
To: APICORE US LLC
Reel/Frame 033315/0712 →
Merger and Change of Name Aug 19, 2015
From: APICORE LLC; APICORE US LLC
To: APICORE US LLC
Reel/Frame 036356/0691 →
Assignment of Assignor's Interest Sep 28, 2015
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; THAKOR, SANJAY F.; NAIK, ASHISH
To: APICORE US LLC
Reel/Frame 036671/0654 →
Assignment of Assignor's Interest Nov 25, 2015
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; RAMU, VASANTHAKUMAR G.; PRASAD, ALAPARTHI LAKSHMI
To: APICORE US LLC
Reel/Frame 037143/0300 →
Assignment of Assignor's Interest Apr 4, 2016
From: KOVI, RAVISHANKER; NAIK, ASHISH; FADADU, PIYUSH; KANNAPAN, JAYARAMAN
To: APICORE US LLC
Reel/Frame 038186/0264 →
Assignment of Assignor's Interest Jul 7, 2016
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; THAKOR, SANJAY F; NAIK, ASHISH
To: APICORE US LLC
Reel/Frame 039100/0550 →
Assignment of Assignor's Interest Aug 5, 2016
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; RAMU, VASANTHAKUMAR C; PRASAD, ALAPARTHI LAKSHMI
To: APICORE US LLC
Reel/Frame 039357/0595 →
Release of Security Interest Jan 9, 2017
From: KNIGHT THERAPEUTICS INC.
To: APICORE LLC
Reel/Frame 040904/0362 →
Release of Security Interest Jan 9, 2017
From: KNIGHT THERAPEUTICS INC.
To: APICORE US LLC
Reel/Frame 040904/0390 →
Security Interest Jan 31, 2017
From: APICORE US LLC
To: MEDICURE INC.
Reel/Frame 041577/0821 →
Assignment of Assignor's Interest Sep 29, 2017
From: APICORE US LLC
To: APICORE LLC
Reel/Frame 043743/0457 →
Assignment of Assignor's Interest Sep 29, 2017
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; THAKOR, SANJAY F; PATEL, RAJESH A
To: APICORE US LLC
Reel/Frame 043740/0143 →
Assignment of Assignor's Interest Nov 2, 2017
From: APICORE LLC
To: APICORE US LLC
Reel/Frame 044016/0764 →
Assignment of Assignor's Interest Oct 4, 2021
From: MYLAN API US LLC
To: MYLAN LABORATORIES LIMITED
Reel/Frame 057685/0916 →
Assignment of Assignor's Interest Oct 4, 2021
From: MYLAN API US LLC
To: MYLAN PHARMACEUTICALS INC.
Reel/Frame 057686/0024 →
Assignment of Assignor's Interest Oct 4, 2021
From: MYLAN API US LLC
To: MYLAN INSTITUTIONAL LLC
Reel/Frame 057686/0088 →
Change of Name Oct 4, 2021
From: APICORE US LLC
To: MYLAN API US LLC
Reel/Frame 057697/0758 →
Assignment of Assignor's Interest Jul 8, 2026
From: MYLAN PHARMACEUTICALS INC.
To: MYLAN LABORATORIES LIMITED
Reel/Frame 075206/0497 →
Assignment of Assignor's Interest Jul 16, 2026
From: MYLAN LABORATORIES LIMITED
To: MATRIX PHARMACORP PRIVATE LIMITED
Reel/Frame 075291/0584 →